Skip to content

The value of joint detection of different biomarkers in blood in the diagnosis and treatment of traumatic brain injury

The value of joint detection of different biomarkers in blood in the diagnosis and treatment of traumatic brain injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107494
Enrollment
Unknown
Registered
2025-08-12
Start date
2024-08-13
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic brain injury

Interventions

Gold Standard:Head CT
Index test:After centrifugation of whole blood samples, serum was collected for detection of NSE, GFAP, S100B, Tau, MBP (myelin basic protein), NFL, IL-6, IL-8, IL-10, IL-1 ß, TNF - a, UCH-L1, P-Tau,
Detection of NSE in cerebrospinal fluid samples GFAPTauNFL Blood brain barrier index (cerebrospinal fluid albumin/serum albumin), etc. The remaining specimens were frozen at -80 ° C in a refrigerator

Sponsors

The First Affiliated Hospital of PLA Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 80 cases of traumatic brain injury group, inclusion criteria: 1. The age range is 18 to 65 years old. 2. According to the Glasgow Coma Scale (GCS) score, patients with mild traumatic brain injury score 13-15 points, patients with moderate traumatic brain injury score 9-12 points, and patients with severe traumatic brain injury score 3-8 points. 3. Injury time: Within 24 hours of acute traumatic brain injury. 4. No other system damage. 5. First visit and hospitalization after injury. 80 cases of fracture control group,inclusion criteria for: 1. Age: 18-65 years old; 2. Injury time: Patients with simple limb or spinal fractures within 24 hours; 3. No other system damage; 4. First visit and hospitalization after injury

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1.History of neurological or psychiatric disorders; 2. Prior to this injury, there was a traumatic brain injury; 3.History of alcohol or drug abuse; 4. Complications caused by mild traumatic brain injury combined with other injuries (systemic trauma, facial trauma, or spinal cord trauma) or other reasons (psychological trauma, language disorders); 5.Patients who are lost during treatment and have incomplete information.

Design outcomes

Primary

MeasureTime frame
NSE;glial fibrillary acidic protein;S100 Calcium-Binding Protein B;Microtubule-Associated Protein Tau;Myelin Basic Protein;Neurofilament Light Chain;Interleukin 6;Interleukin 8;Interleukin 10;Interleukin 1ß;Tumor Necrosis Factor Alpha;Ubiquitin Carboxyl-Terminal Hydrolase L1;Phosphorylated neuronal microtubule-associated protein;Brain-Derived Neurotrophic Factor;Vascular Endothelial Growth Factor;

Countries

China

Contacts

Public ContactJunjie Li

The First Affiliated Hospital of PLA Air Force Military Medical University

doctorljj@126.com+86 137 7212 9992

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026